Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Credit agrmnt [a]
Appointed director
|
|
TransMedics Group, Inc. (TMDX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Gordon Stephen (CFO) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Sold 5,000 shares
@ $54.22, valued at
$271.1k
Exercised 5,000 options to buy
@ $16.14, valued at
$80.7k
|
|
| 08/04/2023 |
4
| Ranganath Anil P. (See remarks) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 9,512 shares
@ $0
Granted 14,709 options to buy
@ $93.88, valued at
$1.4M
|
|
| 08/03/2023 |
4
| Hassanein Waleed H (President & CEO) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Sold 727 shares
@ $91.91, valued at
$66.8k
Sold 4,590 shares
@ $92.9, valued at
$426.4k
Sold 2,183 shares
@ $93.77, valued at
$204.7k
|
|
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Khayal Tamer I (Chief Commercial Officer) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Sold 2,974 shares
@ $90.05, valued at
$267.8k
Sold 2,225 shares
@ $90.02, valued at
$200.3k
Exercised 2,974 options to buy
@ $16.14, valued at
$48k
|
|
| 07/06/2023 |
4
| Hassanein Waleed H (President & CEO) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Sold 2,257 shares
@ $81.77, valued at
$184.6k
Sold 4,653 shares
@ $82.74, valued at
$385k
Sold 590 shares
@ $83.49, valued at
$49.3k
|
|
| 05/30/2023 |
4
| KANIA EDWIN M JR (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 1,193 shares
@ $0
Granted 1,916 options to buy
@ $71.33, valued at
$136.7k
|
|
| 05/30/2023 |
4
| TOBIN JAMES R (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 1,193 shares
@ $0
Granted 1,916 options to buy
@ $71.33, valued at
$136.7k
|
|
| 05/30/2023 |
4
| RAINES MERILEE (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 1,193 shares
@ $0
Granted 1,916 options to buy
@ $71.33, valued at
$136.7k
|
|
| 05/30/2023 |
4
| Basile Edward M (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 1,193 shares
@ $0
Granted 1,916 options to buy
@ $71.33, valued at
$136.7k
|
|
| 05/30/2023 |
4
| Gunderson Thomas James (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 1,193 shares
@ $0
Granted 1,916 options to buy
@ $71.33, valued at
$136.7k
|
|
| 05/30/2023 |
4
| Weill David (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 1,193 shares
@ $0
Granted 1,916 options to buy
@ $71.33, valued at
$136.7k
|
|
| 05/30/2023 |
4
| Lovell Stephanie (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 1,193 shares
@ $0
Granted 1,916 options to buy
@ $71.33, valued at
$136.7k
|
|
| 05/02/2023 |
4
| Gordon Stephen (CFO) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Sold 5,000 shares
@ $79.05, valued at
$395.3k
Exercised 5,000 options to buy
@ $16.14, valued at
$80.7k
|
|
| 05/02/2023 |
4
| Hassanein Waleed H (President & CEO) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Sold 5,406 shares
@ $77.84, valued at
$420.8k
Sold 1,759 shares
@ $78.65, valued at
$138.3k
Sold 335 shares
@ $80.12, valued at
$26.8k
|
|
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Hassanein Waleed H (President & CEO) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Sold 3,359 shares
@ $74.34, valued at
$249.7k
Sold 3,577 shares
@ $75.14, valued at
$268.8k
Sold 564 shares
@ $75.73, valued at
$42.7k
|
|
| 03/14/2023 |
4
| Hassanein Waleed H (President & CEO) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Exercised 193,074 options to buy
@ $2.21, valued at
$426.7k
|
|
| 03/02/2023 |
4
| Hassanein Waleed H (President & CEO) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Sold 2,600 shares
@ $80.17, valued at
$208.4k
Sold 4,900 shares
@ $81.01, valued at
$396.9k
|
|
| 03/02/2023 |
4
| Gordon Stephen (CFO) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Sold 5,000 shares
@ $79.51, valued at
$397.6k
Exercised 5,000 options to buy
@ $16.14, valued at
$80.7k
|
|
| 03/02/2023 |
4
| KANIA EDWIN M JR (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Acquired 145,601 shares
@ $79.76, valued at
$11.6M
Acquired 96,876 shares
@ $79.76, valued at
$7.7M
|
|
| 03/02/2023 |
4
| Khayal Tamer I (Chief Commercial Officer) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Sold 10,000 shares
@ $80.15, valued at
$801.5k
Sold 5,000 shares
@ $80.06, valued at
$400.3k
Exercised 10,000 options to buy
@ $16.14, valued at
$161.4k
|
|
| 03/02/2023 |
4
| Basile Edward M (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Sold 3,500 shares
@ $80.1, valued at
$280.4k
|
|
| 02/28/2023 |
4
| Weill David (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Sold 964 shares
@ $77.64, valued at
$74.8k
Sold 4,970 shares
@ $76.51, valued at
$380.3k
Exercised 5,934 options to buy
@ $14.2, valued at
$84.3k
|
|
| 02/28/2023 |
4
| Basile Edward M (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Sold 1,500 shares
@ $76.2, valued at
$114.3k
Sold 1,500 shares
@ $78.17, valued at
$117.3k
Sold 2,000 shares
@ $79.38, valued at
$158.8k
|
|
| 02/27/2023 |
4
| Hassanein Waleed H (President & CEO) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Sold 6,200 shares
@ $70.31, valued at
$435.9k
Sold 4,807 shares
@ $71.32, valued at
$342.8k
Sold 3,577 shares
@ $73.43, valued at
$262.7k
Sold 3,243 shares
@ $74.52, valued at
$241.7k
Sold 20,000 shares
@ $75.15, valued at
$1.5M
|
|
| 02/27/2023 |
4
| TOBIN JAMES R (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Sold 10,000 shares
@ $75.13, valued at
$751.3k
|
|
| 02/27/2023 |
4
| Khayal Tamer I (Chief Commercial Officer) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Sold 6,319 shares
@ $70.18, valued at
$443.5k
Sold 1,763 shares
@ $71.46, valued at
$126k
Sold 6,218 shares
@ $72.02, valued at
$447.8k
Sold 777 shares
@ $73.55, valued at
$57.1k
Sold 853 shares
@ $74.67, valued at
$63.7k
Sold 20,000 shares
@ $75.15, valued at
$1.5M
Exercised 32,179 options to buy
@ $16, valued at
$514.9k
Exercised 3,751 options to buy
@ $16.14, valued at
$60.5k
|
|
| 02/22/2023 |
4
| Provost Miriam (VP, Global Regulatory Affairs) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 5,685 shares
@ $0
Granted 8,705 options to buy
@ $66.1, valued at
$575.4k
|
|
| 02/22/2023 |
4
| Khayal Tamer I (Chief Commercial Officer) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 13,075 shares
@ $0
Granted 20,022 options to buy
@ $66.1, valued at
$1.3M
|
|
| 02/22/2023 |
4
| DAMME LAURA (VP, Clinical Affairs) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 5,685 shares
@ $0
Granted 8,705 options to buy
@ $66.1, valued at
$575.4k
|
|
| 02/22/2023 |
4
| Corcoran Nicholas (See Remarks) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 12,886 shares
@ $0
Granted 19,732 options to buy
@ $66.1, valued at
$1.3M
|
|
| 02/22/2023 |
4
| Hassanein Waleed H (President & CEO) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 37,332 shares
@ $0
Granted 57,165 options to buy
@ $66.1, valued at
$3.8M
|
|
| 02/22/2023 |
4
| Gordon Stephen (CFO) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 13,075 shares
@ $0
Granted 20,022 options to buy
@ $66.1, valued at
$1.3M
|
|
|
|
|